Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
12.21
+0.38 (3.21%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Cartesian Therapeutics Market Cap

Cartesian Therapeutics has a market cap or net worth of $316.33 million as of April 29, 2025. Its market cap has increased by 224.77% in one year.

Market Cap
316.33M
Enterprise Value
117.70M
1-Year Change
224.77%
Ranking
Category
Stock Price
$12.21

Market Cap Chart

Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $316.33M, an increase of 33.58%. That is a compound annual growth rate of 3.32%.

History

DateMarket Cap% Change
Apr 28, 2025316.30M-30.51%
Dec 31, 2024455.20M325.42%
Dec 29, 2023107.00M-38.11%
Dec 30, 2022172.90M-54.54%
Dec 31, 2021380.30M16.19%
Dec 31, 2020327.30M185.35%
Dec 31, 2019114.70M92.13%
Dec 31, 201859.70M-72.75%
Dec 29, 2017219.10M-29.78%
Dec 30, 2016312.00M31.76%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 779.84B
UnitedHealth Group 380.24B
Johnson & Johnson 373.06B
AbbVie 338.21B
Novo Nordisk 272.76B
Abbott Laboratories 224.66B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings